403 related articles for article (PubMed ID: 10441098)
1. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.
Aukrust P; Müller F; Ueland T; Berget T; Aaser E; Brunsvig A; Solum NO; Forfang K; Frøland SS; Gullestad L
Circulation; 1999 Aug; 100(6):614-20. PubMed ID: 10441098
[TBL] [Abstract][Full Text] [Related]
2. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
Garlichs CD; Eskafi S; Raaz D; Schmidt A; Ludwig J; Herrmann M; Klinghammer L; Daniel WG; Schmeisser A
Heart; 2001 Dec; 86(6):649-55. PubMed ID: 11711459
[TBL] [Abstract][Full Text] [Related]
3. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.
Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218
[TBL] [Abstract][Full Text] [Related]
4. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE
Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
Damås JK; Otterdal K; Yndestad A; Aass H; Solum NO; Frøland SS; Simonsen S; Aukrust P; Andreassen AK
Circulation; 2004 Aug; 110(8):999-1005. PubMed ID: 15302794
[TBL] [Abstract][Full Text] [Related]
6. Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome.
Setianto BY; Hartopo AB; Gharini PP; Anggrahini DW; Irawan B
Heart Vessels; 2010 Jul; 25(4):282-7. PubMed ID: 20676835
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
Wang CL; Wu YT; Liu CA; Lin MW; Lee CJ; Huang LT; Yang KD
Pediatrics; 2003 Feb; 111(2):E140-7. PubMed ID: 12563087
[TBL] [Abstract][Full Text] [Related]
8. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
Sandberg WJ; Yndestad A; Øie E; Smith C; Ueland T; Ovchinnikova O; Robertson AK; Müller F; Semb AG; Scholz H; Andreassen AK; Gullestad L; Damås JK; Frøland SS; Hansson GK; Halvorsen B; Aukrust P
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):857-63. PubMed ID: 16424351
[TBL] [Abstract][Full Text] [Related]
9. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.
Danese S; Katz JA; Saibeni S; Papa A; Gasbarrini A; Vecchi M; Fiocchi C
Gut; 2003 Oct; 52(10):1435-41. PubMed ID: 12970136
[TBL] [Abstract][Full Text] [Related]
10. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.
Varo N; Libby P; Nuzzo R; Italiano J; Doria A; Schönbeck U
Diab Vasc Dis Res; 2005 May; 2(2):81-7. PubMed ID: 16308911
[TBL] [Abstract][Full Text] [Related]
11. CD40L activation in circulating platelets in patients with acute coronary syndrome.
Lee Y; Lee WH; Lee SC; Ahn KJ; Choi YH; Park SW; Seo JD; Park JE
Cardiology; 1999; 92(1):11-6. PubMed ID: 10640791
[TBL] [Abstract][Full Text] [Related]
12. Inverse correlation between soluble CD40 ligand and soluble CD40 is absent in patients with unstable angina.
Tsuzuki M; Morishima I; Yoshida T; Hayashi Y; Miura M; Hirai T; Asai T; Numaguchi Y; Sone T; Matsui H; Okumura K; Murohara T
Heart Vessels; 2005 Nov; 20(6):245-50. PubMed ID: 16314905
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets.
Damås JK; Waehre T; Yndestad A; Otterdal K; Hognestad A; Solum NO; Gullestad L; Frøland SS; Aukrust P
Circulation; 2003 Jun; 107(21):2670-6. PubMed ID: 12742982
[TBL] [Abstract][Full Text] [Related]
14. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation.
Smith C; Damås JK; Otterdal K; Øie E; Sandberg WJ; Yndestad A; Waehre T; Scholz H; Endresen K; Olofsson PS; Halvorsen B; Gullestad L; Frøland SS; Hansson GK; Aukrust P
J Am Coll Cardiol; 2006 Oct; 48(8):1591-9. PubMed ID: 17045893
[TBL] [Abstract][Full Text] [Related]
16. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P;
Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833
[TBL] [Abstract][Full Text] [Related]
17. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
18. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.
Yan JC; Zhu J; Gao L; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2004 May; 343(1-2):155-9. PubMed ID: 15115688
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Choudhury A; Chung I; Panja N; Patel J; Lip GYH
Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
[TBL] [Abstract][Full Text] [Related]
20. Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intake.
Giannini S; Falcinelli E; Bury L; Guglielmini G; Rossi R; Momi S; Gresele P
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2072-9. PubMed ID: 21378140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
